Literature DB >> 17286799

Affinity maturation of immunoglobulin A anti-tissue transglutaminase autoantibodies during development of coeliac disease.

A Westerlund1, M Ankelo, S Simell, J Ilonen, M Knip, O Simell, A E Hinkkanen.   

Abstract

Coeliac disease (CD) is an immune-mediated enteropathy triggered by ingestion of wheat gluten and related cereals in genetically predisposed individuals. Circulating immunoglobulin A (IgA) class autoantibodies against tissue transglutaminase (IgA-TGA) are highly specific and sensitive serological markers for CD, which is ultimately confirmed by duodenal biopsy. Although CD is considered a life-long disorder, transient or fluctuating IgA-TGA seropositivity has been observed in asymptomatic individuals on a gluten-containing diet. We set out to explore possible differences in the maturation of IgA-TGA avidity between individuals progressing to CD and subjects remaining healthy despite occasional expression of autoantibodies. We developed a time-resolved fluorometric IgA-TGA assay based on human recombinant tissue transglutaminase (tTG), and further modified the method to also measure urea-dependent avidity of the autoantibodies. We measured the autoantibody titres and avidities of sequential serum samples from 10 children developing CD and 10 children presenting transient or fluctuating autoantibodies. Both the initial titres at seroconversion and peak values of transient/fluctuating IgA-TGA were significantly lower than corresponding autoantibody titres in samples drawn from individuals with progressing CD (P = 0.004 and P = 0.0002, respectively). However, there were no statistically significant differences in the initial or peak avidity index values between the two groups of children. The avidity index values increased during the follow-up period (P = 0.013 for both groups) with no significant difference in the rate of avidity maturation between children with transient/fluctuating IgA-TGA and children developing CD. According to our results, high autoantibody titres have a higher predictive value than avidity maturation of TGA-IgA in screening for CD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286799      PMCID: PMC1868886          DOI: 10.1111/j.1365-2249.2007.03336.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  The prevalence of celiac disease in at-risk groups of children in the United States.

Authors:  I Hill; A Fasano; R Schwartz; D Counts; M Glock; K Horvath
Journal:  J Pediatr       Date:  2000-01       Impact factor: 4.406

2.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 3.  Is celiac disease a lifelong disorder?

Authors:  J Schmitz
Journal:  Clin Invest Med       Date:  1996-10       Impact factor: 0.825

4.  Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort.

Authors:  A Kupila; P Muona; T Simell; P Arvilommi; H Savolainen; A M Hämäläinen; S Korhonen; T Kimpimäki; M Sjöroos; J Ilonen; M Knip; O Simell
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

5.  Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.

Authors:  Annette Westerlund; Matti Ankelo; Jorma Ilonen; Mikael Knip; Olli Simell; Ari E Hinkkanen
Journal:  J Autoimmun       Date:  2005-03       Impact factor: 7.094

Review 6.  Celiac disease-associated autoimmune endocrinopathies.

Authors:  V Kumar; M Rajadhyaksha; J Wortsman
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

7.  Antibodies against human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease.

Authors:  A Bürgin-Wolff; I Dahlbom; F Hadziselimovic; C J Petersson
Journal:  Scand J Gastroenterol       Date:  2002-06       Impact factor: 2.423

Review 8.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

9.  Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease.

Authors:  Edwin Liu; Fei Bao; Katherine Barriga; Dongmei Miao; Liping Yu; Henry A Erlich; Joel E Haas; George S Eisenbarth; Marian J Rewers; Edward J Hoffenberg
Journal:  Clin Gastroenterol Hepatol       Date:  2003-09       Impact factor: 11.382

10.  Prevalence of Celiac disease among children in Finland.

Authors:  Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

View more
  3 in total

1.  Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases.

Authors:  F Ferrara; S Quaglia; I Caputo; C Esposito; M Lepretti; S Pastore; R Giorgi; S Martelossi; G Dal Molin; N Di Toro; A Ventura; T Not
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

2.  Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease.

Authors:  K A Gelderman; A C A D Drop; L A Trouw; H J Bontkes; G Bouma; I M W van Hoogstraten; B M E von Blomberg
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Anti-Lipid IgG Antibodies Are Produced via Germinal Centers in a Murine Model Resembling Human Lupus.

Authors:  Carlos Wong-Baeza; Albany Reséndiz-Mora; Luis Donis-Maturano; Isabel Wong-Baeza; Luz Zárate-Neira; Juan Carlos Yam-Puc; Juana Calderón-Amador; Yolanda Medina; Carlos Wong; Isabel Baeza; Leopoldo Flores-Romo
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.